.png){kind=icon}
返回
Progress in biopharmaceutical development
.png){kind=icon}
OA
AI
DOI：10.1002/bab.1617.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Since its introduction in 1982, biopharmaceutical drugs have revolutionized the treatment of a broad spectrum of diseases and are increasingly used in nearly all branches of medicine. In recent years, the biopharmaceuticals market has developed much faster than the market for all drugs and is believed to have great potential for further dynamic growth because of the tremendous demand for these drugs. Biobetters, which contain altered active pharmaceutical ingredients with enhanced efficacy, will play an important role in the development of biopharmaceuticals. Another significant group of biopharmaceuticals are biosimilars. Their introduction in the European Union and, recently, the Unites States markets will reduce the costs of biopharmaceutical treatment. This review highlights recent progress in the field of biopharmaceutical development and issues concerning the registration of innovative biopharmaceuticals and biosimilars. The leading class of biopharmaceuticals, the current biopharmaceuticals market, and forecasts are also discussed.
Keyword:
biobetter
biopharmaceutical
biosimilar
drug market
monoclonal antibodies
recombinant vaccines
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
2.7
论文数:
2.7K
被引数:
4.5K
机构
引用论文
Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection.png)
NATURE MEDICINE
NATURE MEDICINEIF50
PREAI
分享收藏Robust production of recombinant phosphoproteins using cell-free protein synthesisNATURE COMMUNICATIONSOAAI
NATURE COMMUNICATIONSIF15.7
OAAI分享收藏
查看更多内容